This module was delivered entirely in Spanish.
La Sociedad Dominicana de Neurología y Neurocirugía en conjunto con el Children’s Hospital of Philadelphia CHOP, tienen el placer de invitarlos a la charla “Neurogenética, la próxima frontera” donde se va a discutir la evaluación genética de los pacientes con epilepsia, incluyendo las pruebas que se solicitan basadas en los síntomas del paciente.
Doctora Pamela Pojomovsky McDonnell, MD, es neuróloga pedíatra en la División de Neurología del Hospital de Niños de Filadelfia (CHOP). Ella se especializa en ayudar a niños con epilepsia y está entusiasmada con los nuevos desarrollos en genética que algún día podrían predecir el curso de la epilepsia e identificar tratamientos mas certeros.
Doctora Evelyn Lora -Alvarez es pediatra neuróloga egresada del Hospital Infantil Federico Gómez en México. Es egresada del Hospital Infantil Robert Reid Cabral en la República Dominicana. Ejerce en la actualidad el cargo de Presidente de la Sociedad Dominicana de Neurología y Neurocirugía.
The Dominican Society of Neurology and Neurosurgery in conjunction with the Children’s Hospital of Philadelphia (CHOP) are pleased to invite you to view this talk: “Neurogenetics, The Next Frontier,” where we discussed genetic testing of patients with epilepsy, including tests that are requested according to patients’ symptoms.
Doctor Pamela Pojomovsky McDonnell, MD, is a pediatric neurologist in the Division of Neurology of Children’s Hospital of Pennsylvania (CHOP). She specializes in helping children with epilepsy and is interested in the newest developments in genetics that may some day predict the course of epilepsy and identify targeted treatments.
Doctor Evelyn Lora Alvarez is a pediatric neurologist, and is an alumna of Children’s Hospital Federico Gómez in Mexico and Robert Reid Cabral Hospital in the Dominican Republic. She is current president of the Dominican Society of Neurology and Neurosurgery.
This seminar focuses on neurology and was delivered at a virtual event titled, Neurogenetica, La Proxima Fontera, on April 22, 2021.
Additional CHOP Resources:
The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.
CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.
To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.
Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.
You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.
The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.
By starting this module, you agree to our Content Disclaimer and Terms of Service.